Clinical course, diagnosis and treatment of gastrointestinal stromal tumors

Yulyi V. Ivanov

doi:10.17816/clinpract83851

Journal of Clinical Practice ›› 2012, Vol. 3 ›› Issue (1) : 59 -64. DOI: 10.17816/clinpract83851

Articles

research-article

Clinical course, diagnosis and treatment of gastrointestinal stromal tumors

Yulyi V. Ivanov

Author information +

History +

PDF

Abstract

The article summarizes up-to-date data of the pathogenesis, diagnosis, and treatment conceptions of the stromal tumors of gastrointestinal tract (GIST). Prognostic factors for progression (recurrence or metastasis) for GIST are reported. Special attention is given to immuno-histochemical method of diagnostics and target therapy for these kinds of tumors.

We present the case history of successful operation in a patient with giant intestinal stromal tumor of the stomach, sprouting into neighbouring organs and tissues.

Keywords

GIST / surgery / imatinib / sunitinib

Cite this article

Download citation ▾

Yulyi V. Ivanov. Clinical course, diagnosis and treatment of gastrointestinal stromal tumors. Journal of Clinical Practice, 2012, 3(1): 59-64 DOI:10.17816/clinpract83851

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Blay J.Y., Bonvalot S., Casali P. et al. for the GIST Consensus Meeting Panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol.

[2]	Vol. 16. P.566-578.

[3]	Demetri G.D., van Oosterom A.T., Garrett C.R. et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet.

[4]	Vol.368. P.1329-1338.

[5]	Heinrich M.C., Maki R.G., Corless C.L. et al. Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor. J Clin Oncol. 2008. Vol.26. P.5352-5359.

[6]	Dewar A.L., Cambareri A.C., Zannettino A.C. et al. Macrophage colony-stimulating factor receptor c- fms is a novel target of imatinib. Blood. 2005. Vol. 105. P.3127-3132.

[7]	Joensuu H. Gastrointestinal stromal tumor (GIST). Ann Oncol. 2006. Vol.17 (suppl. 10). P.280-286.

[8]	Cohen M.H., Johnson J.R., Pazdur R. Full acknowledgement of application (STI571; Gleevec) Clin Cancer Res. 2005. Vol.ll. P.12-19.

[9]	Orosz Z., Tornoczky T., Sapi Z. Gastrointestinal stromal tumors: aclinicopathologic and immunohistochemical study of 136 cases. Pathol Oncol Res. 2005. Vol.ll. Pl 1-21.